TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SBM Life Science AB
Closing information (x1000 SEK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
198,302
|
179,947
|
214,273 |
| Financial expenses |
3,233
|
6,067
|
5,307 |
| Earnings before taxes |
744
|
-1,360
|
4,214 |
| EBITDA |
3,971
|
3,837
|
8,986 |
| Total assets |
122,684
|
104,790
|
166,764 |
| Current assets |
121,882
|
103,714
|
165,796 |
| Current liabilities |
105,484
|
88,164
|
148,884 |
| Equity capital |
17,200
|
16,626
|
17,880 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
15
|
18
|
19 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
14.0%
|
15.9%
|
10.7% |
| Turnover per employee |
13,220
|
9,997
|
11,278 |
| Profit as a percentage of turnover |
0.4%
|
-0.8%
|
2.0% |
| Return on assets (ROA) |
3.2%
|
4.5%
|
5.7% |
| Current ratio |
115.5%
|
117.6%
|
111.4% |
| Return on equity (ROE) |
4.3%
|
-8.2%
|
23.6% |
| Change turnover |
18,355
|
-34,326
|
11,286 |
| Change turnover % |
10%
|
-16%
|
6% |
| Chg. No. of employees |
-3
|
-1
|
-8 |
| Chg. No. of employees % |
-17%
|
-5%
|
-30% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.